Subject Predicate Object
P7O6v9vI
a
Resource
Answer
Written answer
answer has question
EZzdZSar
answer has answering person
Stephen Charles Brine
answer text
<p>In November 2018, my Rt. hon. Friend the Secretary of State for Health and Social Care, met with Roche to discuss life sciences, and briefly discussed the negotiations between Roche and NHS England on ocrelizumab. Similarly, the former Parliamentary Under-Secretary of State for Health (Lord O’Shaughnessy) met with Roche in December 2018. Both Ministers encouraged the on-going negotiations and agreed that these negotiations needed to continue in order to ensure the best conclusion for both parties, and patients that suffer from primary progressive multiple sclerosis. Those discussions are rightly for NHS England and Roche and it would not be appropriate for Ministers to intervene.</p><p> </p><p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of ocrelizumab for the treatment of primary progressive multiple sclerosis. NHS England is in discussions with Roche, the manufacturer of ocrelizumab, to seek to agree a commercial agreement that might enable NICE to recommend use of the drug.</p>
answer given date
answer has answering body
Department of Health and Social Care
written answer has answering body
Department of Health and Social Care
Department of Health and Social Care
answering body has written answer
P7O6v9vI
answering body has answer
P7O6v9vI
EZzdZSar
question has answer
P7O6v9vI
Stephen Charles Brine
answering person has answer
P7O6v9vI